• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Safety of Vancomycin Use Through Midline Catheters for Outpatient Parenteral Antimicrobial Therapy.

作者信息

Paje David, Walzl Emily, Heath Megan, McLaughlin Elizabeth, Horowitz Jennifer K, Tatarcuk Caitlin, Swaminathan Lakshmi, Kaatz Scott, Malani Anurag N, Gupta Ashwin, Vaughn Valerie M, Bernstein Steven J, Flanders Scott A, Chopra Vineet

机构信息

Division of Hospital Medicine, Department of Internal Medicine, Michigan Medicine, University of Michigan, Ann Arbor.

The Hospital Medicine Safety Consortium Coordinating Center, Ann Arbor, Michigan.

出版信息

JAMA Intern Med. 2025 Sep 1;185(9):1162-1164. doi: 10.1001/jamainternmed.2025.3110.

DOI:10.1001/jamainternmed.2025.3110
PMID:40690240
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12281390/
Abstract
摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0bd4/12281390/714b2ca2c859/jamainternmed-e253110-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0bd4/12281390/714b2ca2c859/jamainternmed-e253110-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0bd4/12281390/714b2ca2c859/jamainternmed-e253110-g001.jpg

相似文献

1
Safety of Vancomycin Use Through Midline Catheters for Outpatient Parenteral Antimicrobial Therapy.通过中线导管进行门诊肠外抗菌治疗时使用万古霉素的安全性。
JAMA Intern Med. 2025 Sep 1;185(9):1162-1164. doi: 10.1001/jamainternmed.2025.3110.
2
The Association of Vasopressor Administration through a Midline Catheter with Catheter-related Complications.中线导管给药与导管相关并发症的关联。
Ann Am Thorac Soc. 2023 Jul;20(7):1003-1011. doi: 10.1513/AnnalsATS.202209-814OC.
3
Infiltration and Extravasation Risk with Midline Catheters: A Narrative Literature Review.中线导管渗液和外渗风险：文献叙事性综述。
J Infus Nurs. 2024;47(5):324-346. doi: 10.1097/NAN.0000000000000566. Epub 2024 Aug 27.
4
Midline vs Peripherally Inserted Central Catheter for Outpatient Parenteral Antimicrobial Therapy.门诊肠外抗菌治疗中使用中线导管与外周静脉穿刺中心静脉导管的比较。
JAMA Intern Med. 2025 Jan 1;185(1):83-91. doi: 10.1001/jamainternmed.2024.5984.
5
Catheter impregnation, coating or bonding for reducing central venous catheter-related infections in adults.用于降低成人中心静脉导管相关感染的导管浸渍、涂层或粘结
Cochrane Database Syst Rev. 2016 Mar 16;3(3):CD007878. doi: 10.1002/14651858.CD007878.pub3.
6
Prophylactic antibiotics for preventing gram-positive infections associated with long-term central venous catheters in adults and children receiving treatment for cancer.预防抗生素用于预防与成人和儿童癌症治疗期间长期使用中心静脉导管相关的革兰氏阳性感染。
Cochrane Database Syst Rev. 2021 Oct 7;10(10):CD003295. doi: 10.1002/14651858.CD003295.pub4.
7
Percutaneous central venous catheters versus peripheral cannulae for delivery of parenteral nutrition in neonates.经皮中心静脉导管与外周套管用于新生儿肠外营养输注的比较
Cochrane Database Syst Rev. 2015 Oct 6;2015(10):CD004219. doi: 10.1002/14651858.CD004219.pub4.
8
Prescription of Controlled Substances: Benefits and Risks管制药品的处方：益处与风险
9
Can Oritavancin Be Used for Treatment and/or Suppressive Antimicrobial Therapy of Bone and Joint Infections Caused by Vancomycin-resistant Enterococcus faecium?奥利万星可用于治疗和/或抑制耐万古霉素屎肠球菌引起的骨和关节感染吗？
Clin Orthop Relat Res. 2025 Mar 14;483(7):1225-33. doi: 10.1097/CORR.0000000000003449.
10
Are Oritavancin and Dalbavancin More Cost Effective for Outpatient Parenteral Antimicrobial Therapy at a Veterans Affairs Medical Center?在一家退伍军人事务医疗中心，奥利万星和达巴万星用于门诊胃肠外抗菌治疗时成本效益更高吗？
Fed Pract. 2025 Jun;42(6):236-243b. doi: 10.12788/fp.0571. Epub 2025 Jun 17.

本文引用的文献

1
Midline vs Peripherally Inserted Central Catheter for Outpatient Parenteral Antimicrobial Therapy.门诊肠外抗菌治疗中使用中线导管与外周静脉穿刺中心静脉导管的比较。
JAMA Intern Med. 2025 Jan 1;185(1):83-91. doi: 10.1001/jamainternmed.2024.5984.
2
Infusion Therapy Standards of Practice, 9th Edition.《输液治疗实践标准》第9版
J Infus Nurs. 2024;47(1S Suppl 1):S1-S285. doi: 10.1097/NAN.0000000000000532.
3
Effectiveness and Safety of Linezolid Versus Vancomycin, Teicoplanin, or Daptomycin against Methicillin-Resistant Bacteremia: A Systematic Review and Meta-Analysis.
利奈唑胺与万古霉素、替考拉宁或达托霉素治疗耐甲氧西林菌血症的有效性和安全性：一项系统评价和荟萃分析。
Antibiotics (Basel). 2023 Apr 2;12(4):697. doi: 10.3390/antibiotics12040697.
4
Risk of thrombophlebitis associated with continuous peripheral infusion of vancomycin: The effect of dilution.万古霉素持续外周静脉输注相关的血栓性静脉炎风险：稀释的影响。
J Vasc Access. 2024 Jan;25(1):107-112. doi: 10.1177/11297298221095778. Epub 2022 May 24.
5
Meta-analysis of vancomycin versus linezolid in pneumonia with proven methicillin-resistant Staphylococcus aureus.万古霉素与利奈唑胺治疗耐甲氧西林金黄色葡萄球菌性肺炎的荟萃分析。
J Glob Antimicrob Resist. 2021 Mar;24:98-105. doi: 10.1016/j.jgar.2020.12.009. Epub 2021 Jan 2.